Sodium taurocholate hydrate inhibits influenza virus replication and suppresses influenza a Virus-triggered inflammation in vitro and in vivo

Krammer, 2018, Influenza, Nature reviews. Disease primers, 4, 3, 10.1038/s41572-018-0002-y Shanks, 2015, Insights from unusual aspects of the 1918 influenza pandemic, Travel Med Infect Dis, 13, 217, 10.1016/j.tmaid.2015.05.001 Viboud, 2016, Global Mortality Impact of the 1957–1959 Influenza Pandemic, J Infect Dis, 213, 738, 10.1093/infdis/jiv534 Jester, 2020, Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968, Am J Public Health, 110, 669, 10.2105/AJPH.2019.305557 York, 2013, The 2009 pandemic influenza virus: where did it come from, where is it now, and where is it going?, Curr Top Microbiol Immunol, 370, 241 Shortridge, 1998, Characterization of avian H5N1 influenza viruses from poultry in Hong Kong, Virology, 252, 331, 10.1006/viro.1998.9488 Claas, 1998, Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus, Lancet, 351, 472, 10.1016/S0140-6736(97)11212-0 Lupiani, 2009, The history of avian influenza, Comp Immunol Microbiol Infect Dis, 32, 311, 10.1016/j.cimid.2008.01.004 Poovorawan, 2013, Global alert to avian influenza virus infection: from H5N1 to H7N9, Pathog Glob Health, 107, 217, 10.1179/2047773213Y.0000000103 Lu, 2013, The outbreak of avian influenza A (H7N9) in China: current status and future prospects, Biomed J, 36, 96, 10.4103/2319-4170.113224 De, 2018, Molecular evolution of hemagglutinin gene of Influenza A virus, Front Biosci (Schol Ed), 10, 101, 10.2741/s502 Zhang, 2017, Novel antigenic shift in HA sequences of H1N1 viruses detected by big data analysis, Infect Genet Evol, 51, 138, 10.1016/j.meegid.2017.03.028 Petrova, 2018, The evolution of seasonal influenza viruses, Nat Rev Microbiol, 16, 47, 10.1038/nrmicro.2017.118 Wang, 2022, Progress towards the Development of a Universal Influenza Vaccine, Viruses, 14, (8) Hussain, 2017, Drug resistance in influenza A virus: the epidemiology and management, Infect Drug Resist, 10, 121, 10.2147/IDR.S105473 McKimm-Breschkin, 2013, Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance, Influenza Other Respir Viruses, 7, 25, 10.1111/irv.12047 Noshi, 2018, In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit, Antiviral Res, 160, 109, 10.1016/j.antiviral.2018.10.008 Deyde, 2007, Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide, Journal of Infectious Diseases, 196, 249, 10.1086/518936 Li, 2015, Clinical Implications of Antiviral Resistance in Influenza, Viruses, 7, 4929, 10.3390/v7092850 Argmann, C. A.; Houten, S. M.; Champy, M. F.; Auwerx, J., Lipid and bile acid analysis. Curr Protoc Mol Biol 2006, Chapter 29, Unit 29B 2. Glaser, 2010, Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats, Dig Liver Dis, 42, 709, 10.1016/j.dld.2010.02.008 Wang, 2013, Effects of taurocholic acid on immunoregulation in mice, Int Immunopharmacol, 15, 217, 10.1016/j.intimp.2012.12.006 Perez, J. T.; Garcia-Sastre, A.; Manicassamy, B., Insertion of a GFP reporter gene in influenza virus. Curr Protoc Microbiol 2013, Chapter 15, Unit 15G 4. Tan, 2015, A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms, J Virol, 89, 3712, 10.1128/JVI.03014-14 Julkunen, 2000, Inflammatory responses in influenza A virus infection, Vaccine, 19, S32, 10.1016/S0264-410X(00)00275-9 Mayer, 2019, Hijacking the Supplies: Metabolism as a Novel Facet of Virus-Host Interaction, Front Immunol, 10, 1533, 10.3389/fimmu.2019.01533 Shah, 2015, Comparative mapping of host-pathogen protein-protein interactions, Curr Opin Microbiol, 27, 62, 10.1016/j.mib.2015.07.008 Tong, 2022, A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2, Nat Metab, 4, 547, 10.1038/s42255-022-00567-z Sohail, 2022, Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection, PLoS pathogens, 18, (1), e1010219, 10.1371/journal.ppat.1010219 Houten, 2006, Endocrine functions of bile acids, EMBO J, 25, 1419, 10.1038/sj.emboj.7601049 Thomas, 2008, Targeting bile-acid signalling for metabolic diseases, Nat Rev Drug Discov, 7, 678, 10.1038/nrd2619 Duboc, 2013, Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases, Gut, 62, 531, 10.1136/gutjnl-2012-302578 Jones, 2014, The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention, Expert Opin Biol Ther, 14, 467, 10.1517/14712598.2014.880420 Luo, 2018, Chenodeoxycholic Acid from Bile Inhibits Influenza A Virus Replication via Blocking Nuclear Export of Viral Ribonucleoprotein Complexes, Molecules, 23, (12), 10.3390/molecules23123315 Mooranian, 2015, The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study, Drug Deliv Transl Re, 5, 511, 10.1007/s13346-015-0248-9 Chiang, 2013, Bile acid metabolism and signaling, Compr Physiol, 3, 1191, 10.1002/cphy.c120023 Khatun, 2013, Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy, J Control Release, 170, 74, 10.1016/j.jconrel.2013.04.024 Aho, 1983, Experimental pancreatitis in the rat. Development of pancreatic necrosis, ischemia and edema after intraductal sodium taurocholate injection, Eur Surg Res, 15, 28, 10.1159/000128330 Chan, 2007, Acute pancreatitis - Animal models and recent advances in basic research, Pancreas, 34, 1, 10.1097/01.mpa.0000246658.38375.04 Zhang, X.; Xia, Y.; Yang, L.; He, J.; Li, Y.; Xia, C., Brevilin A, a Sesquiterpene Lactone, Inhibits the Replication of Influenza A Virus In Vitro and In Vivo. Viruses 2019, 11, (9). Scull, 2010, A big role for small RNAs in influenza virus replication, Proc Natl Acad Sci U S A, 107, 11153, 10.1073/pnas.1006673107 Kumar, 2008, NF-kappa B Signaling Differentially Regulates Influenza Virus RNA Synthesis, J Virol, 82, 9880, 10.1128/JVI.00909-08 Ito, 2021, Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo, Hepatology, 74, 83, 10.1002/hep.31712 Manicassamy, 2010, Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus, P Natl Acad Sci USA, 107, 11531, 10.1073/pnas.0914994107 Ibricevic, 2006, Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells, J Virol, 80, 7469, 10.1128/JVI.02677-05 Brandes, 2013, A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection, Cell, 154, 197, 10.1016/j.cell.2013.06.013 de Jong, 2006, Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia, Nat Med, 12, 1203, 10.1038/nm1477 Perrone, 2008, H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice, PLoS Pathog, 4, (8), e1000115, 10.1371/journal.ppat.1000115 Zheng, 2008, Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus, P Natl Acad Sci USA, 105, 8091, 10.1073/pnas.0711942105 Flory, 2000, Influenza virus-induced NF-kappa B-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of I kappa B kinase, J Biol Chem, 275, 8307, 10.1074/jbc.275.12.8307 Gack, 2009, Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I, Cell Host Microbe, 5, 439, 10.1016/j.chom.2009.04.006 Ludwig, 2006, Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells, Cell Microbiol, 8, 375, 10.1111/j.1462-5822.2005.00678.x Imai, 2008, Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury, Cell, 133, 235, 10.1016/j.cell.2008.02.043 Nhu, 2010, Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo, Mucosal Immunol, 3, 29, 10.1038/mi.2009.120 Shirey, 2013, The TLR4 antagonist Eritoran protects mice from lethal influenza infection, Nature, 497, 498, 10.1038/nature12118 Kumar, 2008, NF-kappaB signaling differentially regulates influenza virus RNA synthesis, J Virol, 82, 9880, 10.1128/JVI.00909-08 Santoro, 2003, NF-kappaB and virus infection: who controls whom, EMBO J, 22, 2552, 10.1093/emboj/cdg267